Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - ACCELERON PHARMA INC | a2216342zs-1a.htm |
| EX-3.4 - EX-3.4 - ACCELERON PHARMA INC | a2216342zex-3_4.htm |
| EX-10.17 - EX-10.17 - ACCELERON PHARMA INC | a2216342zex-10_17.htm |
| EX-10.19 - EX-10.19 - ACCELERON PHARMA INC | a2216342zex-10_19.htm |
| EX-10.18 - EX-10.18 - ACCELERON PHARMA INC | a2216342zex-10_18.htm |
| EX-10.13 - EX-10.13 - ACCELERON PHARMA INC | a2216342zex-10_13.htm |
| EX-10.14 - EX-10.14 - ACCELERON PHARMA INC | a2216342zex-10_14.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated July 3, 2013, in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-190417) and related Prospectus of Acceleron Pharma Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Boston,
Massachusetts
August 19, 2013
Consent of Independent Registered Public Accounting Firm